CVS Bay Area Inc. Revises Earnings Forecast — Net Profit Plummets
CVS Bay Area Inc. (TSE:2687) has revised its earnings forecast for the fiscal year ending February 2026, citing significant non-operating losses and impairment charges.
| Item | Before | After | Change |
|---|---|---|---|
| Revenue | JPY 8.03bn | JPY 7.90bn | -1.6% |
| Operating Profit | JPY 167M | JPY 130M | -22.2% |
| Ordinary Income | JPY 89M | △64 | — |
| Net Profit | △44 | △1140 | — |
| EPS | △8.96 | △230.91 | — |
The company attributed the downward revision to a combination of non-operating expenses and special losses. Specifically, it recorded a ¥1.2bn gain from the sale of investment securities as non-operating income, while incurring ¥930m in non-operating expenses from the operation of investment partnerships. Additionally, the firm recognized a ¥6.17bn impairment loss on fixed assets and a ¥402m tax adjustment related to deferred tax assets. These items collectively led to a sharp decline in net profit, which is now projected to reach JPY 1,140m in the fiscal year ending February 2026, compared to a previous forecast of JPY 44m.
The revision highlights the impact of non-operating and special items on the company’s financial results, which is common in Japan’s accounting framework. Investors should closely monitor the company’s financial health and future performance, particularly given the material impact of these one-time charges on its bottom line.